Elite in Endometrial Cancer

Dr. Emma L. Barber

Oncology
Northwestern Medical Group
250 E Superior St Ste 4-420, Prentice Women's Hospital, 
Chicago, IL 
Clinical Trials:Currently Recruiting for 1 Trial
Offers Telehealth
20 Years of Experience
Elite in Endometrial Cancer
Northwestern Medical Group
250 E Superior St Ste 4-420, Prentice Women's Hospital, 
Chicago, IL 
OverviewInsuranceLocationsClinical ResearchSimilar Doctors

Overview

Emma Barber is an Oncologist in Chicago, Illinois. Dr. Barber has been practicing medicine for over 20 years and is rated as an Elite provider by MediFind in the treatment of Endometrial Cancer. Her top areas of expertise are Endometrial Cancer, Ovarian Cancer, Ovarian Carcinosarcoma, Vulvectomy, and Endoscopy.

Her clinical research consists of co-authoring 94 peer reviewed articles and participating in 7 clinical trials. MediFind looks at clinical research from the past 15 years. In particular, she has co-authored 16 articles and participated in 2 clinical trials in the study of Endometrial Cancer.

Graduate Institution
Yale University School Of Medicine, 2006.0
Residency
McGaw Medical Center of Northwestern University
Specialties
Oncology
Licenses
Obstetrics & Gynecology in IL
Board Certifications
American Board Of Obstetrics And Gynecology - Gynecologic Oncology (Certified)
Fellowships
University of North Carolina Hospitals
Hospital Affiliations
Northwestern Memorial Hospital
Northwestern Lake Forest Hospital
Palos Community Hospital
Northwestern Medicine Delnor Community Hospital
Northwestern Medicine Central Dupage Hospital
Languages Spoken
English
Gender
Female

Insurance

Accepted insurance can change. Please verify directly with the provider.

Find your insurance
Find your insuranceClose

Accepted insurance plans:

Aetna
  • EPO
  • HMO
  • POS
  • PPO
Anthem BCBS
  • EPO
  • HMO
  • POS
  • PPO
Cigna
  • EPO
  • HMO
  • PPO
Health Care Services Corporation
  • HMO
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • MEDICARE SNP
  • OTHER COMMERCIAL
  • OTHER MEDICARE
  • OTHER MEDICARE PART D
  • PPO
Humana
  • HMO
  • INDEMNITY
  • POS
  • PPO
Managed Medicaid
  • OTHER MANAGED MEDICAID
Medicaid
  • OTHER MEDICAID
  • STATE MEDICAID
Meridian Choice
  • HMO
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE SNP
  • MEDICARE-MEDICAID PLAN
  • OTHER COMMERCIAL
  • OTHER MEDICARE
  • OTHER MEDICARE PART D
UnitedHealthcare
  • EPO
  • HMO
  • POS
  • PPO
Wellcare
  • EPO
  • HMO
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • MEDICARE SNP
  • MEDICARE-MEDICAID PLAN
  • OTHER MEDICARE
  • OTHER MEDICARE PART D
View 5 Less Insurance Carriers -

Locations

250 E Superior St Ste 4-420, Prentice Women's Hospital, Chicago, IL 60611
Call: 866-587-4322

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Providers who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

7 Clinical Trials

A Phase 1/1b Dose Escalation Study of Abemaciclib and Olaparib for Recurrent Platinum-Resistant Ovarian Cancer
A Phase 1/1b Dose Escalation Study of Abemaciclib and Olaparib for Recurrent Platinum-Resistant Ovarian Cancer
Enrollment Status: Recruiting
Publish Date: February 12, 2026
Intervention Type: Drug, Procedure
Study Drug: Abemaciclib
Study Phase: Phase 1
A Phase III Randomized Trial of Radiation +/- Pembrolizumab (MK-3475) for Newly Diagnosed Early Stage High Intermediate Risk Mismatch Repair Deficient (dMMR) Endometrioid Endometrial Cancer
A Phase III Randomized Trial of Radiation +/- Pembrolizumab (MK-3475) for Newly Diagnosed Early Stage High Intermediate Risk Mismatch Repair Deficient (dMMR) Endometrioid Endometrial Cancer
Enrollment Status: Active_not_recruiting
Publish Date: February 12, 2026
Intervention Type: Other, Procedure, Radiation, Biological
Study Drug: Pembrolizumab
Study Phase: Phase 3
Surgical Window of Opportunity Study of Megestrol Acetate Compared With Megestrol Acetate and Metformin for Endometrial Intraepithelial Neoplasia
Surgical Window of Opportunity Study of Megestrol Acetate Compared With Megestrol Acetate and Metformin for Endometrial Intraepithelial Neoplasia
Enrollment Status: Active_not_recruiting
Publish Date: January 21, 2026
Intervention Type: Other, Procedure, Drug
Study Drugs: Extended Release Metformin Hydrochloride, Megestrol Acetate
Study Phase: Phase 2
A Randomized Phase III, Two-Arm Trial of Paclitaxel/Carboplatin/Maintenance Letrozole Versus Letrozole Monotherapy in Patients With Stage II-IV, Primary Low-Grade Serous Carcinoma of the Ovary or Peritoneum
A Randomized Phase III, Two-Arm Trial of Paclitaxel/Carboplatin/Maintenance Letrozole Versus Letrozole Monotherapy in Patients With Stage II-IV, Primary Low-Grade Serous Carcinoma of the Ovary or Peritoneum
Enrollment Status: Active_not_recruiting
Publish Date: January 14, 2026
Intervention Type: Drug, Procedure
Study Drugs: Carboplatin, Letrozole, Paclitaxel
Study Phase: Phase 3
A Pilot, Multicenter, Single Arm, Open Label, Surgical Window of Opportunity Study of Abemaciclib and Letrozole for Endometrioid Adenocarcinoma of the Endometrium
A Pilot, Multicenter, Single Arm, Open Label, Surgical Window of Opportunity Study of Abemaciclib and Letrozole for Endometrioid Adenocarcinoma of the Endometrium
Enrollment Status: Completed
Publish Date: October 20, 2025
Intervention Type: Drug, Procedure
Study Drugs: Abemaciclib, Letrozole
Study Phase: Early Phase 1
A Pilot Study of Prehabilitation During the Neoadjuvant Window of Opportunity in Older Women With Ovarian Cancer (FIT4SURGERY)
A Pilot Study of Prehabilitation During the Neoadjuvant Window of Opportunity in Older Women With Ovarian Cancer (FIT4SURGERY)
Enrollment Status: Completed
Publish Date: April 29, 2025
Intervention Type: Behavioral
Study Phase: Not Applicable
An Open Label Phase II Trial of Guadecitabine and Pembrolizumab in Platinum Resistant Recurrent Ovarian Cancer
An Open Label Phase II Trial of Guadecitabine and Pembrolizumab in Platinum Resistant Recurrent Ovarian Cancer
Enrollment Status: Completed
Publish Date: February 20, 2024
Intervention Type: Drug, Other, Biological
Study Drugs: Guadecitabine, Pembrolizumab
Study Phase: Phase 2
View 6 Less Clinical Trials

93 Total Publications

Health Care Disparities in Gynecologic Oncology.
Health Care Disparities in Gynecologic Oncology.
Journal: Hematology/oncology clinics of North America
Published: October 31, 2025
View All 93 Publications
Similar Doctors
Elite in Endometrial Cancer
Dr. Gini F. Fleming
Hematology Oncology | Hematology | Oncology
Elite in Endometrial Cancer
Dr. Gini F. Fleming
Hematology Oncology | Hematology | Oncology

University Of Chicago

355 E Grand Ave, 
Chicago, IL 
 (0.4 miles away)
888-824-0200
Languages Spoken:
English
See accepted insurances
Accepting New Patients
Offers Telehealth

Gini Fleming is a Hematologist Oncology specialist and a Hematologist in Chicago, Illinois. Dr. Fleming is rated as an Elite provider by MediFind in the treatment of Endometrial Cancer. Her top areas of expertise are Endometrial Cancer, Ovarian Cancer, Breast Cancer, Gastrostomy, and Bone Marrow Aspiration. Dr. Fleming is currently accepting new patients.

Elite in Endometrial Cancer
Dr. Daniela E. Matei
Hematology | Oncology
Elite in Endometrial Cancer
Dr. Daniela E. Matei
Hematology | Oncology
250 E Superior St Ste 4-420, Prentice Women's Hospital, 
Chicago, IL 
 (0.1 miles away)
866-587-4322
Experience:
34+ years
Languages Spoken:
English
See accepted insurances
Offers Telehealth

Daniela Matei is a Hematologist and an Oncologist in Chicago, Illinois. Dr. Matei has been practicing medicine for over 34 years and is rated as a Distinguished provider by MediFind in the treatment of Endometrial Cancer. Her top areas of expertise are Ovarian Cancer, Endometrial Cancer, Ovarian Carcinosarcoma, and Sertoli-Leydig Cell Tumor.

John Moroney
Elite in Endometrial Cancer
Dr. John Moroney
Oncology | Obstetrics and Gynecology
Elite in Endometrial Cancer
Dr. John Moroney
Oncology | Obstetrics and Gynecology

Endeavor Health Medical Group

880 W. Central Rd., Suite 5000, 
Arlington Heights, IL 
 (22.9 miles away)
847-618-3800
Languages Spoken:
English
See accepted insurances
Offers Telehealth

John Moroney is an Oncologist and an Obstetrics and Gynecologist in Arlington Heights, Illinois. Dr. Moroney is rated as a Distinguished provider by MediFind in the treatment of Endometrial Cancer. His top areas of expertise are Endometrial Cancer, Ovarian Cancer, Sertoli-Leydig Cell Tumor, Gastrostomy, and Bladder Reconstruction.

VIEW MORE ENDOMETRIAL CANCER DOCTORS

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Dr. Barber's expertise for a condition
ConditionClose
  • Elite
  • Endometrial Cancer
    Dr. Barber is
    Elite
    . Learn about Endometrial Cancer.
    See more Endometrial Cancer experts
  • Distinguished
  • Ovarian Cancer
    Dr. Barber is
    Distinguished
    . Learn about Ovarian Cancer.
    See more Ovarian Cancer experts
  • Advanced
  • Cervical Cancer
    Dr. Barber is
    Advanced
    . Learn about Cervical Cancer.
    See more Cervical Cancer experts
  • Febrile Neutropenia
    Dr. Barber is
    Advanced
    . Learn about Febrile Neutropenia.
    See more Febrile Neutropenia experts
  • Malignant Mixed Mullerian Tumor
    Dr. Barber is
    Advanced
    . Learn about Malignant Mixed Mullerian Tumor.
    See more Malignant Mixed Mullerian Tumor experts
  • Ovarian Carcinosarcoma
    Dr. Barber is
    Advanced
    . Learn about Ovarian Carcinosarcoma.
    See more Ovarian Carcinosarcoma experts
  • Sertoli-Leydig Cell Tumor
    Dr. Barber is
    Advanced
    . Learn about Sertoli-Leydig Cell Tumor.
    See more Sertoli-Leydig Cell Tumor experts
  • Vulvar Cancer
    Dr. Barber is
    Advanced
    . Learn about Vulvar Cancer.
    See more Vulvar Cancer experts
  • Experienced
  • Adult Soft Tissue Sarcoma
    Dr. Barber is
    Experienced
    . Learn about Adult Soft Tissue Sarcoma.
    See more Adult Soft Tissue Sarcoma experts
  • Agranulocytosis
    Dr. Barber is
    Experienced
    . Learn about Agranulocytosis.
    See more Agranulocytosis experts
  • Anal Cancer
    Dr. Barber is
    Experienced
    . Learn about Anal Cancer.
    See more Anal Cancer experts
  • Appendix Cancer
    Dr. Barber is
    Experienced
    . Learn about Appendix Cancer.
    See more Appendix Cancer experts
  • Desmoplastic Small Round Cell Tumor
    Dr. Barber is
    Experienced
    . Learn about Desmoplastic Small Round Cell Tumor.
    See more Desmoplastic Small Round Cell Tumor experts
  • Endoscopy
    Dr. Barber is
    Experienced
    . Learn about Endoscopy.
    See more Endoscopy experts
View All 14 Experienced Conditions
Want to save this doctor for later?
Sign Up
Is this your doctor?
Find A Second Opinion
Not sure about your diagnosis?
Check Your Symptoms
 
 
 
 
Learn about our expert tiers
Learn More
Are you the provider on this profile?
Claim Profile
For Patients
  • Our Story
  • How MediFind Works
  • Conditions A-Z
  • Doctor Directory
  • Symptoms Directory
  • Procedures Directory
  • Treatment Directory
  • Drug Directory
  • Infusion Center Finder
  • FAQ
  • Contact Us
For Providers and Practices
  • Claim Your Profile
  • Newsroom
Business Solutions
  • Provider
  • Network Solutions
Additional Resources
  • Consumer Health Data Privacy Policy
  • Privacy Policy
  • Terms of Use
  • Advertising Policy
  • Content Policy
Subscribe to our newsletter

Sign up to stay informed about MediFind and get wellness sent your way.

Close

    By subscribing, I agree to MediFind's Terms of Use, Privacy Policy and Consumer Health Data Privacy Policy, as applicable.

    Bullet PinMediFind
    Follow us on
    This information is not intended as a substitute for informed medical advice. You should work with a licensed professional to diagnose and treat health conditions. We let the data speak for itself, MediFind does not endorse any healthcare providers.
    © 2026 All Rights Reserved

    Request an Appointment

    If you are experiencing a medical emergency, call 9-1-1.

    MediFind will contact the provider for your appointment request. You’ll receive status updates by email. Your provider or MediFind will reach out to you directly by phone or email to schedule your appointment or request additional information.

    Patient Details

    This information is for the patient who will be seen at the appointment.

      Close

      Returning patient? Use your address on file with the provider.

      Insurance Details

      Please provide information of the primary insurance holder as the practice may require this information to schedule.

      Insurance Provider *
      Insurance ProviderClose

      Appointments Details

      Let’s get more information about your appointment.

              0 / 1000
              0 / 1000
              By pressing the Submit button you are agreeing to MediFind’s Terms of Use, Privacy Policy and Consumer Health Data Privacy Policy, as applicable.